Liebig's Extractum Carnis (LEMCO)

The name on every jar

Printed on every jar of Liebig’s Extract of Meat was the signature of Justus von Liebig (1803-1873), and that signature was the product. Liebig, Freiherr (Baron) von Liebig from 1845, held the chemistry chair at Giessen from 1824 and at Munich from 1852, and was universally regarded as the greatest chemist of his era. He had built the first systematic university teaching laboratory in Europe, trained virtually every prominent mid-century organic chemist, and published the foundational texts of agricultural and animal chemistry. His authority was not merely reputational: it was institutionally embedded in the research universities of Germany and the scientific societies of Britain, France, and the United States. When Liebig endorsed a nutritional product, it carried the weight of what his contemporaries would have recognized as the best chemistry in the world.

Science for those who could pay for it

The intervention occupied a premium niche from the outset. LEMCO first marketed its products through physicians and apothecaries, accompanying each shipment with pamphlets describing the extract’s medicinal and nutritional virtues and targeting the prescribing class directly. Pricing placed it above most households: the premium version of nourishment for invalids, convalescents, officers, explorers, and the urban professional class who could afford to improve their diet or the diets of their sick dependants. Florence Nightingale and the hospital-diet reformers debated it; polar and military expeditions carried it; Liebig’s signature appeared on every jar. The early LEMCO product was not food for the poor but a scientific preparation for those who could pay for science.

The wrong fraction of the beef

The mechanism was Liebig’s theory of nitrogen and vital force. He held that the water-soluble nitrogenous fraction of meat, chiefly albuminoids and kreatin, constituted meat’s essential nutritive principle. Muscle tissue was continuously rebuilt from dietary albuminoids and muscular work was fuelled by their catabolism; the extract, concentrating these substances from approximately 34 pounds of beef into one pound of dark paste, therefore delivered their nutritive power in a portable and convenient form. The theory was biochemically plausible at the level of chemical identification: Liebig had genuinely isolated nitrogenous compounds from meat. What he had not done was demonstrate that the particular fraction concentrated in the extract was the nutritive fraction, or that creatine and creatinine, the dominant nitrogenous species in the water-soluble phase, contributed to tissue building rather than being waste products. The mechanistic language was correct; its application to the extract was wrong.

A lump sum, a salary, and 2% of profits

Liebig was named scientific director of LEMCO on its incorporation, 4 December 1865, and received an immediate lump sum of £5,000, an annual salary of £1,000, and 2% of the company’s profits for five years. These were the financial terms recorded by Brock (2017) and Finlay (1992). Scholars have noted that the meat extract was the only invention that made Liebig significant personal income. His arrangement was explicit and publicly known: LEMCO used Liebig’s name and signature as its primary marketing asset, printing his name on every jar and advertising the product as his scientific discovery. The conflict was a founding condition of the enterprise, not a later complication.

The dogs that ate nothing else

The scientific case against the extract was assembled within the decade of LEMCO’s founding. The Lancet published critical analyses in 1865, the year of LEMCO’s incorporation, arguing that the extract contained almost no usable protein. Swedish chemist August Almén subjected the product to rigorous chemical analysis and found it consisted mainly of salts, creatine, and creatinine: molecules he identified as metabolic waste products without nutritive value. Almén calculated that a similar mixture of salts could be prepared for approximately 1% of the extract’s price and concluded that its nutritive value was ‘almost nil.’ He closed his published commentary with the Latin ‘Mundus vult decipi, ergo decipiatur.’ In 1868, physiologist Edward Kemmerich fed dogs exclusively on the extract; all died, a result he published as evidence that the extract could not sustain life. The broader theoretical pillar also fell: Fick and Wislicenus’s 1865 Faulhorn mountain-ascent self-experiment, and Voit and Pettenkofer’s Munich respiratory chamber studies from 1866 onward, established that muscular work was fuelled substantially by carbohydrates and fats, not protein alone, dismantling the theory that concentrated nitrogenous substances were the essential source of physical energy. LEMCO ceased advertising in medical and pharmaceutical publications after 1874. Liebig died in 1873 and his signature continued to appear on the jars long after the scientific basis for his claims had been rejected.

Notes

On 4 December 1865 a British company incorporated in London with a capital of £150,000 under the name Liebig’s Extract of Meat Company (LEMCO). Its scientific director was Justus von Liebig, then the most celebrated chemist alive. His terms, recorded by Brock (2017): an immediate payment of £5,000, an annual salary of £1,000, and 2% of the company’s profits for five years. Liebig’s signature appeared on every jar, functioning as both authentication and advertisement. The company had been set up by Georg Christian Giebert, a German railway engineer who had approached Liebig in 1862 with the observation that South American cattle, slaughtered primarily for their hides, could supply beef at a cost low enough to make large-scale meat extract production viable. LEMCO’s factory at Villa Independencia (soon renamed Fray Bentos) on the Uruguay River opened in 1866. Within a decade the company was processing hundreds of thousands of jars annually.

The product’s scientific case rested entirely on Liebig’s nutritional theory, set out in his 1847 Researches on the Chemistry of Food. Liebig held that the nitrogenous organic constituents of food, principally albumin and related albuminoids, were the body’s essential nutritive material: tissue was built and rebuilt from dietary protein, and muscular energy was supplied by its catabolism. The water-soluble nitrogenous fraction of meat, which passed into the broth when beef was simmered in water, therefore concentrated what Liebig took to be meat’s vital essence. The extract, made from approximately 34 pounds of fresh beef per pound of finished product, was marketed as delivering the equivalent nutritive value in a convenient form. LEMCO’s promotional materials, initially aimed at physicians and apothecaries, described the product as invaluable for invalids and convalescents and as able to sustain soldiers and explorers when solid food was unavailable.

The scientific critique arrived almost simultaneously with the product. The Lancet published critical analyses in 1865, the year of LEMCO’s founding, arguing that the extract lacked the protein content the marketing implied. Swedish chemist August Almén, writing in the Proceedings of the Upsala Medical Society, subjected the extract to systematic chemical analysis and found that its nitrogenous content consisted primarily of creatine and creatinine: small molecules that are metabolic waste products excreted via the kidneys. Almén noted that these compounds contributed nothing to tissue building or energy supply and that the extract’s protein and fat content were negligible. His conclusion: the nutritive value of Liebig’s extract was almost nil, and an equivalent mixture of salts could be prepared for about 1% of the price. The 34-pounds figure was mathematically accurate but biologically misleading: what was concentrated from 34 pounds of beef was the water-soluble fraction, which is the flavour and waste-product fraction, not the nutritive fraction. Protein and fat, the genuine nutritive constituents of meat, are not water-soluble; they remain in the spent carcass residue that LEMCO discarded.

In 1868 physiologist Edward Kemmerich fed dogs exclusively on the extract. All the dogs died, a result Kemmerich published as evidence that the extract could not sustain life and was, in concentrated doses, potentially harmful. The broader theoretical foundation also collapsed during this decade. Adolf Fick and Johannes Wislicenus climbed the Faulhorn mountain in August 1865 on a protein-restricted diet and measured their nitrogen excretion; the nitrogen they excreted was insufficient to account for the mechanical work of the ascent, demonstrating that carbohydrates and fats must supply a substantial share of muscular energy (Heggie, 2016). From 1866 Carl von Voit and Max von Pettenkofer measured oxygen consumption, carbon dioxide production, and nitrogen excretion in a sealed human respiratory chamber in Munich; their data showed that energy expenditure during work could not be explained by protein catabolism alone. The theoretical pillar supporting meat extract as a concentrated energy food had been dismantled by experiment before the end of the decade.

LEMCO withdrew its advertising from medical and pharmaceutical publications after 1874, roughly coinciding with the completion of the experimental refutations. The company repositioned its products for the domestic market, emphasising flavour and convenience rather than nutritional or medical virtue. Liebig had died in April 1873 at age 69, having published his continuing endorsement of the product as recently as 1872 and having seen the experimental refutations accumulate during the final decade of his life without revising his public position; his signature continued to appear on LEMCO’s jars long after his death. The company’s products eventually evolved into OXO cubes, sold today as a culinary flavouring with no nutritional or health claims. The case presents the archive’s cleanest example of a practitioner whose scientific standing was genuine, whose specific application was wrong, and whose commercial interest was formally and explicitly structured before the experimental verdict was in.